This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Sunderland. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ivan Hales: Innovator in Pharmaceutical Chemistry
Introduction
Ivan Hales is a notable inventor based in Middlesbrough, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of prodrugs. His work focuses on improving the efficacy and delivery of therapeutic compounds.
Latest Patents
Ivan Hales holds a patent for the production processes of S- and O-diacylated gamma-glutamyl-cysteamine prodrugs. This patent outlines methods for synthesizing a compound of a specific formula, where Ris can be selected from various alkyl, alkenyl, and aryl groups. Additionally, the patent describes intermediate compounds formed during the synthesis process, which are crucial for the development of these prodrugs.
Career Highlights
Ivan is affiliated with the University of Sunderland, where he continues to advance his research in pharmaceutical sciences. His innovative approaches have garnered attention in the academic community, contributing to the advancement of drug development.
Collaborations
Ivan has collaborated with notable colleagues, including Rosaleen Joy Anderson and Lisa Frost. Their combined expertise enhances the research output and fosters a collaborative environment for innovation.
Conclusion
Ivan Hales exemplifies the spirit of innovation in pharmaceutical chemistry through his patent and collaborative efforts. His work not only contributes to scientific knowledge but also has the potential to impact therapeutic practices significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile